GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Medimaging Integrated Solution Inc (TPE:6796) » Definitions » Altman Z-Score

Medimaging Integrated Solution (TPE:6796) Altman Z-Score : 3.67 (As of Dec. 13, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Medimaging Integrated Solution Altman Z-Score?

The Altman Z-Score is a model designed to predict the likelihood of a company going bankrupt within the next two years. Created by American finance professor Edward Altman in 1968, the model is specifically designed for publicly traded manufacturing companies with assets greater than $1 million.

Good Sign:

Altman Z-score of 3.73 is strong.

Medimaging Integrated Solution has a Altman Z-Score of 3.67, indicating it is in Safe Zones. This implies the Altman Z-Score is strong.

The zones of discrimination were as such:

When Altman Z-Score <= 1.8, it is in Distress Zones.
When Altman Z-Score >= 3, it is in Safe Zones.
When Altman Z-Score is between 1.8 and 3, it is in Grey Zones.

The historical rank and industry rank for Medimaging Integrated Solution's Altman Z-Score or its related term are showing as below:

TPE:6796' s Altman Z-Score Range Over the Past 10 Years
Min: 3.61   Med: 6.38   Max: 12.62
Current: 3.73

During the past 6 years, Medimaging Integrated Solution's highest Altman Z-Score was 12.62. The lowest was 3.61. And the median was 6.38.


Medimaging Integrated Solution Altman Z-Score Historical Data

The historical data trend for Medimaging Integrated Solution's Altman Z-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medimaging Integrated Solution Altman Z-Score Chart

Medimaging Integrated Solution Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Altman Z-Score
Get a 7-Day Free Trial - - 6.91 9.18 5.54

Medimaging Integrated Solution Quarterly Data
Dec18 Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Altman Z-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.29 5.54 4.09 3.87 3.61

Competitive Comparison of Medimaging Integrated Solution's Altman Z-Score

For the Medical Devices subindustry, Medimaging Integrated Solution's Altman Z-Score, along with its competitors' market caps and Altman Z-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medimaging Integrated Solution's Altman Z-Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Medimaging Integrated Solution's Altman Z-Score distribution charts can be found below:

* The bar in red indicates where Medimaging Integrated Solution's Altman Z-Score falls into.



Medimaging Integrated Solution Altman Z-Score Calculation

Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

Medimaging Integrated Solution's Altman Z-Score for today is calculated with this formula:

Z=1.2*X1+1.4*X2+3.3*X3+0.6*X4+1.0*X5
=1.2*0.4123+1.4*-0.0125+3.3*-0.003+0.6*4.7369+1.0*0.3609
=3.67

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z-Score when X4 or X5 value is 0.

Trailing Twelve Months (TTM) ended in Sep. 2024:
Total Assets was NT$1,313.1 Mil.
Total Current Assets was NT$743.5 Mil.
Total Current Liabilities was NT$202.0 Mil.
Retained Earnings was NT$-16.4 Mil.
Pre-Tax Income was -25.924 + 5.46 + -12.069 + 20.694 = NT$-11.8 Mil.
Interest Expense was -2.116 + -2.051 + -2.046 + -1.667 = NT$-7.9 Mil.
Revenue was 104.134 + 122.532 + 97.103 + 150.107 = NT$473.9 Mil.
Market Cap (Today) was NT$2,873.8 Mil.
Total Liabilities was NT$606.7 Mil.

* Note that for stock reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data.

X1=Working Capital/Total Assets
=(Total Current Assets - Total Current Liabilities)/Total Assets
=(743.45 - 202.025)/1313.105
=0.4123

X2=Retained Earnings/Total Assets
=-16.411/1313.105
=-0.0125

X3=Earnings Before Interest and Taxes/Total Assets
=(Pre-Tax Income - Interest Expense)/Total Assets
=(-11.839 - -7.88)/1313.105
=-0.003

X4=Market Value Equity/Book Value of Total Liabilities
=Market Cap/Total Liabilities
=2873.825/606.689
=4.7369

X5=Revenue/Total Assets
=473.876/1313.105
=0.3609

The zones of discrimination were as such:

Distress Zones - 1.81 < Grey Zones < 2.99 - Safe Zones

Medimaging Integrated Solution has a Altman Z-Score of 3.67 indicating it is in Safe Zones.

Study by Altman found that companies that are in Distress Zone have more than 80% of chances of bankruptcy in two years.


Medimaging Integrated Solution  (TPE:6796) Altman Z-Score Explanation

X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.

X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.

X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.

X4, Market Value of Equity/Book Value of Total Liabilities (MVE/TL): The measure shows how much the firm's assets can decline in value (measured by market value of equity plus debt) before the liabilities exceed the assets and the firm becomes insolvent.

X5, Revenue/Total Assets (S/TA): The capital-turnover ratio is a standard financial ratio illustrating the sales generating ability of the firm's assets.

Read more about Altman Z-Score and the original research.


Be Aware

Altman Z-Score does not apply to financial companies.


Medimaging Integrated Solution Altman Z-Score Related Terms

Thank you for viewing the detailed overview of Medimaging Integrated Solution's Altman Z-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Medimaging Integrated Solution Business Description

Traded in Other Exchanges
N/A
Address
No.24-2, Industry E. Road IV, 3rd Floor, Hsinchu Science Park, Hsinchu, TWN, 30077
Medimaging Integrated Solution Inc is in the medical device sector. The company is involved in the design and manufacturing of digital hand-held diagnostic scopes. The company also produces auxiliary tools to enhance the effectiveness and efficiency of healthcare practice. It earns revenue through selling medical products and also by providing designing and development services for medical equipment and related software.

Medimaging Integrated Solution Headlines

No Headlines